![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Apotex Launches First Generic Version of Merck’s Nasonex Spray
Apotex Launches First Generic Version of Merck’s Nasonex Spray
Apotex has launched the first generic version of Merck’s once-daily Nasonex spray, the drugmaker announced last week.
Nasonex raked in roughly $955.5 million in sales in a 12-month period that ended in January, according to IMS Health.
In June 2013, the Federal Circuit upheld a decision that Apotex had not infringed patents covering the drug.
Upcoming Events
-
21Oct